Creditos
Bus.Valor
Conectar
Bus.User
Desde:
11/01/2017
OFF:
8 Hor
Recordad también que el futuro es la robótica aumentada con inteligencia artificial (TSLA, NVDA, etc.) A ver si ahora esta empresa hará honor a sus siglas .
0
Si recuerdo bien se habló de yacimientos de algunas tierras raras en sus terrenos. A ver si anuncian algún plan de desarrollo en ese sentido.
0
¿Alguien tiene info. sobre los temas tratados en el 1er Foro de Iversores de Libertas hoy en Valencia?
0
Según copilot la fecha límite para presentar la solicitud de homologación judicial del plan de reestrucuración es el 31/10/2025.
0
Royalty Simulation
Let’s say Jazz achieves $300 million in annual net sales from the combination therapy:
High teens tier (e.g., 18%) ? $54 million/year to PharmaMar
Upper tier (e.g., 30%) ? $90 million/year to PharmaMar
We could layer in milestone triggers too:
If this approval unlocks a regulatory milestone, PharmaMar might receive a one-time payment (e.g., $50–100 million depending on the milestone tier).
If sales accelerate, commercial milestones could be triggered in increments (e.g., $100M, $250M, $500M thresholds).
Let’s say Jazz achieves $300 million in annual net sales from the combination therapy:
High teens tier (e.g., 18%) ? $54 million/year to PharmaMar
Upper tier (e.g., 30%) ? $90 million/year to PharmaMar
We could layer in milestone triggers too:
If this approval unlocks a regulatory milestone, PharmaMar might receive a one-time payment (e.g., $50–100 million depending on the milestone tier).
If sales accelerate, commercial milestones could be triggered in increments (e.g., $100M, $250M, $500M thresholds).
0
Mensaje de: limbo2 Hora: 03/10/2025 12:34:24
Preguntando a Chat gpt: PharmaMar is entitled to tiered royalties ranging from the high teens up to..........
Preguntando a Chat gpt: PharmaMar is entitled to tiered royalties ranging from the high teens up to..........
Manufacturing and Supply
PharmaMar retains production rights for lurbinectedin and supplies the product to Jazz, which handles commercialization in the U.S..
This structure ensures PharmaMar benefits both from the initial regulatory success and ongoing commercial performance. The recent FDA approval of the combination therapy could trigger additional milestone payments, depending on the terms and thresholds defined in the original agreement. If you"d like, I can help model the royalty impact based on projected sales or simulate milestone triggers.
PharmaMar retains production rights for lurbinectedin and supplies the product to Jazz, which handles commercialization in the U.S..
This structure ensures PharmaMar benefits both from the initial regulatory success and ongoing commercial performance. The recent FDA approval of the combination therapy could trigger additional milestone payments, depending on the terms and thresholds defined in the original agreement. If you"d like, I can help model the royalty impact based on projected sales or simulate milestone triggers.
3
Mensaje de: limbo2 Hora: 03/10/2025 12:34:24
Preguntando a Chat gpt: PharmaMar is entitled to tiered royalties ranging from the high teens up to..........
Preguntando a Chat gpt: PharmaMar is entitled to tiered royalties ranging from the high teens up to..........
One-Time and Milestone Payments
Upfront payment: Jazz paid PharmaMar $200 million upon signing the exclusive license agreement in 2019.
Regulatory milestone payments: PharmaMar is eligible for up to $250 million based on FDA approvals within certain timelines.
Commercial milestone payments: PharmaMar may receive up to $550 million based on commercial performance benchmarks.
Upfront payment: Jazz paid PharmaMar $200 million upon signing the exclusive license agreement in 2019.
Regulatory milestone payments: PharmaMar is eligible for up to $250 million based on FDA approvals within certain timelines.
Commercial milestone payments: PharmaMar may receive up to $550 million based on commercial performance benchmarks.
3
Mostrar mas Mensajes
